106 related articles for article (PubMed ID: 32771892)
21. Bioresponsive and fluorescent hyaluronic acid-iodixanol nanogels for targeted X-ray computed tomography imaging and chemotherapy of breast tumors.
Zhu Y; Wang X; Chen J; Zhang J; Meng F; Deng C; Cheng R; Feijen J; Zhong Z
J Control Release; 2016 Dec; 244(Pt B):229-239. PubMed ID: 27568289
[TBL] [Abstract][Full Text] [Related]
22. Tumor-targeting and pH-sensitive lipoprotein-mimic nanocarrier for targeted intracellular delivery of paclitaxel.
Chen C; Hu H; Qiao M; Zhao X; Wang Y; Chen K; Guo X; Chen D
Int J Pharm; 2015 Mar; 480(1-2):116-27. PubMed ID: 25615984
[TBL] [Abstract][Full Text] [Related]
23. An organic solvent-free technology for the fabrication of albumin-based paclitaxel nanoparticles for effective cancer therapy.
Zhao Y; Cai C; Liu M; Zhao Y; Pei W; Chu X; Zhang H; Wang Z; Han J
Colloids Surf B Biointerfaces; 2019 Nov; 183():110394. PubMed ID: 31398618
[TBL] [Abstract][Full Text] [Related]
24. Albumin nanoparticles increase the anticancer efficacy of albendazole in ovarian cancer xenograft model.
Noorani L; Stenzel M; Liang R; Pourgholami MH; Morris DL
J Nanobiotechnology; 2015 Mar; 13():25. PubMed ID: 25890381
[TBL] [Abstract][Full Text] [Related]
25. Folic acid-coupled nano-paclitaxel liposome reverses drug resistance in SKOV3/TAX ovarian cancer cells.
Tong L; Chen W; Wu J; Li H
Anticancer Drugs; 2014 Mar; 25(3):244-54. PubMed ID: 24275314
[TBL] [Abstract][Full Text] [Related]
26. Long-circulating self-assembled cholesteryl albumin nanoparticles enhance tumor accumulation of hydrophobic anticancer drug.
Battogtokh G; Kang JH; Ko YT
Eur J Pharm Biopharm; 2015 Oct; 96():96-105. PubMed ID: 26212785
[TBL] [Abstract][Full Text] [Related]
27. Extremely long tumor retention, multi-responsive boronate crosslinked micelles with superior therapeutic efficacy for ovarian cancer.
Xiao W; Suby N; Xiao K; Lin TY; Al Awwad N; Lam KS; Li Y
J Control Release; 2017 Oct; 264():169-179. PubMed ID: 28847739
[TBL] [Abstract][Full Text] [Related]
28. MRI-visible liposome nanovehicles for potential tumor-targeted delivery of multimodal therapies.
Ren L; Chen S; Li H; Zhang Z; Ye C; Liu M; Zhou X
Nanoscale; 2015 Aug; 7(30):12843-50. PubMed ID: 26022345
[TBL] [Abstract][Full Text] [Related]
29. Utilizing glutathione-triggered nanoparticles to enhance chemotherapy of lung cancer by reprograming the tumor microenvironment.
Cui T; Li X; Shu Y; Huang X; Wang Y; Zhang W
Int J Pharm; 2018 Dec; 552(1-2):16-26. PubMed ID: 30253209
[TBL] [Abstract][Full Text] [Related]
30. Anti-EGFR lipid micellar nanoparticles co-encapsulating quantum dots and paclitaxel for tumor-targeted theranosis.
Kang SJ; Jeong HY; Kim MW; Jeong IH; Choi MJ; You YM; Im CS; Song IH; Lee TS; Park YS
Nanoscale; 2018 Nov; 10(41):19338-19350. PubMed ID: 30307008
[TBL] [Abstract][Full Text] [Related]
31. RGD-based strategies for improving antitumor activity of paclitaxel-loaded liposomes in nude mice xenografted with human ovarian cancer.
Zhao H; Wang JC; Sun QS; Luo CL; Zhang Q
J Drug Target; 2009 Jan; 17(1):10-8. PubMed ID: 19016068
[TBL] [Abstract][Full Text] [Related]
32. Fabrication of multifunctional Gd2O3/Au hybrid nanoprobe via a one-step approach for near-infrared fluorescence and magnetic resonance multimodal imaging in vivo.
Sun SK; Dong LX; Cao Y; Sun HR; Yan XP
Anal Chem; 2013 Sep; 85(17):8436-41. PubMed ID: 23924153
[TBL] [Abstract][Full Text] [Related]
33. Liposomal nanohybrid cerasomes targeted to PD-L1 enable dual-modality imaging and improve antitumor treatments.
Du Y; Liang X; Li Y; Sun T; Xue H; Jin Z; Tian J
Cancer Lett; 2018 Feb; 414():230-238. PubMed ID: 29175457
[TBL] [Abstract][Full Text] [Related]
34. Nanoparticle-mediated drug delivery to tumor neovasculature to combat P-gp expressing multidrug resistant cancer.
Bai F; Wang C; Lu Q; Zhao M; Ban FQ; Yu DH; Guan YY; Luan X; Liu YR; Chen HZ; Fang C
Biomaterials; 2013 Aug; 34(26):6163-74. PubMed ID: 23706689
[TBL] [Abstract][Full Text] [Related]
35. Drug-induced co-assembly of albumin/catalase as smart nano-theranostics for deep intra-tumoral penetration, hypoxia relieve, and synergistic combination therapy.
Chen Q; Chen J; Liang C; Feng L; Dong Z; Song X; Song G; Liu Z
J Control Release; 2017 Oct; 263():79-89. PubMed ID: 27840167
[TBL] [Abstract][Full Text] [Related]
36. Hydrotropic magnetic micelles for combined magnetic resonance imaging and cancer therapy.
Yoon HY; Saravanakumar G; Heo R; Choi SH; Song IC; Han MH; Kim K; Park JH; Choi K; Kwon IC; Park K
J Control Release; 2012 Jun; 160(3):692-8. PubMed ID: 22543013
[TBL] [Abstract][Full Text] [Related]
37. Free paclitaxel loaded PEGylated-paclitaxel nanoparticles: preparation and comparison with other paclitaxel systems in vitro and in vivo.
Lu J; Chuan X; Zhang H; Dai W; Wang X; Wang X; Zhang Q
Int J Pharm; 2014 Aug; 471(1-2):525-35. PubMed ID: 24858391
[TBL] [Abstract][Full Text] [Related]
38. Anti-tumor activity of paclitaxel through dual-targeting lipoprotein-mimicking nanocarrier.
Chen C; Hu H; Qiao M; Zhao X; Wang Y; Chen K; Chen D
J Drug Target; 2015 May; 23(4):311-22. PubMed ID: 25539074
[TBL] [Abstract][Full Text] [Related]
39. In vivo tailor-made protein corona of a prodrug-based nanoassembly fabricated by redox dual-sensitive paclitaxel prodrug for the superselective treatment of breast cancer.
Zhang D; Yang J; Guan J; Yang B; Zhang S; Sun M; Yang R; Zhang T; Zhang R; Kan Q; Zhang H; He Z; Shang L; Sun J
Biomater Sci; 2018 Aug; 6(9):2360-2374. PubMed ID: 30019051
[TBL] [Abstract][Full Text] [Related]
40. Paclitaxel-loaded hyaluronan solid nanoemulsions for enhanced treatment efficacy in ovarian cancer.
Kim JE; Park YJ
Int J Nanomedicine; 2017; 12():645-658. PubMed ID: 28176896
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]